D1R-5-HT2AR解通过HDAC信号来减少抑郁行为
Weifen Li1,2, Tahir Ali1,3, Shengnan Mou1
1State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, 518055, China.
概括
研究人员在抑郁症中发现了一种新的多巴胺 (D1R) 和血清素 (5-HT2AR) 受体相互作用. 通过HDAC途径破坏这个复合体,用一种降低了通过HDAC途径的抑郁症状,提供了一个新的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 重度抑郁症 (MDD) 是一个全球性的健康问题,治疗效果有限.
- 目前针对多巴胺和胺通路的药物具有副作用和可变的成功率.
- 了解新的信号机制对于开发改进的抑郁症疗法至关重要.
研究的目的:
- 在抑郁症的背景下,研究多巴胺受体1 (D1R) 和血清素受体2A (5-HT2AR) 之间的相互作用.
- 探索受这种D1R/5-HT2AR复合体影响的下游信号通路.
- 评估针对这种异体受体复合体的治疗潜力.
主要方法:
- 在慢性压力下的小鼠大脑中研究了D1R/5-HT2AR复合体的形成.
- 分析了CREB/ERK/AKT路径调制.
- 使用干扰 (TAT-5-HT2AR-SV) 来破坏该复合体.
- 评估了HDAC和TrkB对抗作用对的抗抑郁作用的影响.
主要成果:
- D1R和5-HT2AR在大脑中形成了一个重要的蛋白质复合体,由慢性压力调节.
- 这种相互作用影响了突触调节中的CREB/ERK/AKT信号传递.
- 干扰降低了抑郁行为,并调节了CREB/ERK信号传递.
- 对HDAC的对抗性,但不是TrkB,逆转了该的抗抑郁作用.
结论:
- 一个新的D1R/5-HT2AR异体受体复合体与抑郁症病理生理学有关.
- 破坏这种复合物可以通过依赖HDAC的机制改善抑郁症状.
- 这一发现为抑郁症治疗提供了一个新的治疗策略,与BDNF途径不同.
相关概念视频
G-protein Coupled Receptors
120.1K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
120.1K
Depressive Disorders: MDD and Dysthymia
149
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
149
Antidepressant Drugs: MAOIs and Other Agents
266
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
266
Depressive Disorders: Etiology
114
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
114
Long-term Depression
31.0K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
31.0K
Depression: Overview
271
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
271


